Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Ovarian endometriomas are common manifestations of endometriosis. Surgical excision has been shown to potentially decrease ovarian reserves. In this prospective study, we included 81 patients with ovarian endometriosis. 40 were treated with 2 mg of dienogest daily (DNG) and 41 were treated with cyclic oral estro-progestins (ethinyl estradiol 30 mcg [EE] plus dienogest 2 mg) (DNG + EE). Aim of the study was the effect of the treatment on the size of the endometriotic cysts. Further, in the symptomatic patients, follow-up included an evaluation of chronic pain before and during treatment. Both treatments were able to significantly decrease the pain in symptomatic patients with no statistical differences. The mean visual analog scale score at enrollment was 65 ± 14 and 70 ± 18, and there was significant improvement (19 ± 15, p < .001, DNG; 18 ± 12, p < .001, DNG + EE). The size of the endometrioma cysts were significantly reduced in the DNG group. The mean cyst diameter was 52 ± 22 mm at baseline and 32 ± 12 mm after six months of treatment (p < .001), yielding a 75% volume reduction in DNG group. The decrease in the size of endometrioma cysts observed in the women treated with only progestin could be noteworthy, as it may reduce the negative impacts on the affected ovary and avoid surgery.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DNG alone has been shown to be superior to COCs, containing DNG, to reduce the size of OMAs [192].”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [192]
Citations
Cites
ESHRE guideline: management of women with endometriosis
Dunselman, G. A. J., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D'Hooghe, T., De Bie, B., Heikinheimo, O., Horne, A. W., Kiesel, L., Nap, A., et al. (2014) · Human Reproduction · doi:10.1093/humrep/det457 · Cited by 2,211 · cited 2×
“An ideal hormonal therapy for endo-metriosis should be able to decrease pain while avoiding a hypo-estrogenic state and have limited side effects, as it should be administered for a prolonged period of time [13,14].”
Postsurgical ovarian failure after laparoscopic excision of bilateral endometriomas
Busacca, M., Riparini, J., Somigliana, E., Oggioni, G., Izzo, S., Vignali, M., & Candiani, M. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.03.064 · Cited by 303 · cited 1×
“Conversely, multiple studies show the detrimental effect of surgery on ovarian reserves and the role of surgical technique in reducing this complication [10 – 12].”
Self-citationSeracchioli, R., Mabrouk, M., Frascà, C., Manuzzi, L., Montanari, G., Keramyda, A., & Venturoli, S. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.09.052 · Cited by 228
Casper, R. F. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.01.003 · Cited by 205 · cited 2×
“It is possible that with the addition of a potent estrogen (ethinyl estradiol), this progestin could induce supraphysiological concentrations of estrogens that might act on progesterone-resistant endometriosis cells with increased estrogen activity [16].”
Muzii, L., Achilli, C., Lecce, F., Bianchi, A., Franceschetti, S., Marchetti, C., Perniola, G., & Panici, P. B. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.12.101 · Cited by 141 · cited 1×
“…treatment for endometriosis cysts with and without symptoms has been debated, and the possible negative effects to the reproductive potential of the treated ovary have decreased the number of patients with endometriomas electing to receive surgical treatment, particularly repeated surgeries [17].”
Roman, H., Tarta, O., Pura, I., Opris, I., Bourdel, N., Marpeau, L., & Sabourin, J. C. (2010) · Human Reproduction · doi:10.1093/humrep/deq069 · Cited by 139 · cited 1×
“Roman et al. [18] found that an increase in cyst diameter increased the volume of ovarian tissue removed.”
Melis, I., Litta, P., Nappi, L., Agus, M., Melis, G. B., & Angioni, S. (2015) · International Journal of Sexual Health · doi:10.1080/19317611.2014.952394 · Cited by 122 · cited 1×
“Indeed, many patients suffer chronic pain and the concomitant presence of deep endometriosis is associated with an impaired quality of life [21,22].”
BackgroundSelf-citationAn update on the diagnosis, surgical management, and fertility outcomes for women with endometrioma
Cranney, R., Condous, G., & Reid, S. (2017) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.13114 · Cited by 104 · cited 1×
“Medication and surgery have been used to treat endometriosis, but these methods do not result in long-term cures or symptom elimination [5,6].”
BackgroundSantulli, P., Lamau, M. C., Marcellin, L., Gayet, V., Marzouk, P., Borghese, B., Lafay Pillet, M.-C., & Chapron, C. (2016) · Human Reproduction · doi:10.1093/humrep/dew093 · Cited by 66 · cited 1×
“Conflicting reports exist regarding the impact of an endometrioma on ovarian reserves, particularly when its growth compresses healthy ovarian tissue [8,9].”
BackgroundAssessment of ovarian reserve by antral follicle count in ovaries with endometrioma
Lima, M. L. S., Martins, W. P., Neto, M. A. C., Nastri, C. O., Ferriani, R. A., & Navarro, P. A. (2014) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.14763 · Cited by 61 · cited 1×
“Conflicting reports exist regarding the impact of an endometrioma on ovarian reserves, particularly when its growth compresses healthy ovarian tissue [8,9].”
Background
Research works printed but not linked: 2
- Angioni S, 2017, Minerva Ginecol, 60, 438
- Melis GB, 2005, Giorn It Ost Gin, 27, 293
Cited by
Hormonal treatments for endometriosis: The endocrine background
Vannuccini, S., Clemenza, S., Rossi, M., & Petraglia, F. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09666-w · Cited by 336
A Lifelong Impact on Endometriosis: Pathophysiology and Pharmacological Treatment
Chen, L.-H., Lo, W.-C., Huang, H.-Y., & Wu, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087503 · Cited by 110
Hormonal drugs for the treatment of endometriosis
Capezzuoli, T., Rossi, M., Torre, F. L., Vannuccini, S., & Petraglia, F. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102311 · Cited by 91
Pretreatment with dienogest in women with endometriosis undergoing IVF after a previous failed cycle
Barra, F., Laganà, A. S., Scala, C., Garzon, S., Ghezzi, F., & Ferrero, S. (2020) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.07.022 · Cited by 63
Piacenti, I., Viscardi, M. F., Masciullo, L., Sangiuliano, C., Scaramuzzino, S., Piccioni, M. G., Muzii, L., Panici, P. B., & Porpora, M. G. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1892632 · Cited by 58
“To the best of our knowledge, only one study has compared the effect of dienogest and COC for the treatment of endometriosis [34].”
Background
Metadata
- Authors
- Angioni, S., Pontis, A., Malune, M. E., Cela, V., Luisi, S., Litta, P., Vignali, M., & Nappi, L.
- Affiliations
- University of Cagliari (IT)
- Department of Obstetrics and Gynecology, San Francesco Hospital, Nuoro, Italy;
- University of Pisa (IT)
- University of Siena (IT)
- University of Padua (IT)
- Macedonio Melloni Hospital, Milano, Italy;
- University of Foggia (IT)
- Corresponding author
- Angioni, Stefano
- Venue
- Gynecological Endocrinology
- Publisher
- Informa UK Limited
- Published
- 2019-07-16
- Volume
- 36
- Issue
- 1
- Pages
- 84-86
- ISSN
- 0951-3590 (ISSN-L)
- 1473-0766
- OpenAlex
- W2962367112
- Cited by
- 55
- References
- 24
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 10 · 2023: 13 · 2022: 8 · 2021: 10 · 2020: 3
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gynecological Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Keywords
- dienogest, endometrioma, endometriosis, oral progestogens, ethinyl estradiol, chronic pelvic pain, ovarian reserve
- MeSH terms
- Adult, Contraceptives, Oral, Combined, Endometriosis, Ethinyl Estradiol, Female, Hormone Antagonists, Humans, Nandrolone, Ovarian Diseases, Case-Control Studies, Treatment Outcome, Pelvic Pain, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study. https://app.cochat.ai/papers/10.1080/09513590.2019.1640674
- The paper
- Angioni, S., Pontis, A., Malune, M. E., Cela, V., Luisi, S., Litta, P., Vignali, M., & Nappi, L. (2020). Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study. Gynecological Endocrinology. https://doi.org/10.1080/09513590.2019.1640674
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.